Qualigen Therapeutics Inc (QLGN) — Defensive Interval Ratio
Qualigen Therapeutics Inc (QLGN) has a Defensive Interval Ratio of 322 days as of September 2025. Defensive assets of $4.35 Million (cash $-, short-term investments $-, receivables $4.35 Million) cover 322 days of daily cash needs of $13.49K/day. See working capital position of Qualigen Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Qualigen Therapeutics Inc Defensive Interval Ratio (2017–2024)
This chart shows how Qualigen Therapeutics Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 322 days, meaning defensive assets of $4.35 Million can fund 322 days of operations without new revenue. See Qualigen Therapeutics Inc balance sheet quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Qualigen Therapeutics Inc (2017–2024)
The table below presents the year-by-year Defensive Interval Ratio for Qualigen Therapeutics Inc from 2017 to 2024, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of Qualigen Therapeutics Inc.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 366 days | $2.01 Million | $5.50K/day | $- | $- | ▲ +343 days |
| 2022 | 23 days | $538.59K | $23.58K/day | $- | $- | ▼ -42 days |
| 2021 | 65 days | $822.35K | $12.70K/day | $- | $- | ▲ +43 days |
| 2020 | 22 days | $615.76K | $28.58K/day | $- | $- | ▲ +21 days |
| 2019 | 0 days | $771.00 | $4.65K/day | $- | $- | ▼ -433 days |
| 2018 | 433 days | $7.04 Million | $16.26K/day | $- | $6.99 Million | ▲ +320 days |
| 2017 | 113 days | $838.61K | $7.42K/day | $- | $- | — |